Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD.
暂无分享,去创建一个
Subramaniam Pennathur | Farsad Afshinnia | Stefanie Wernisch | Debbie Gipson | G. Michailidis | D. Gipson | T. Rajendiran | Tanu Soni | S. Pennathur | George Michailidis | K. Bellovich | Jaeman Byun | Thekkelnaycke M. Rajendiran | Tanu Soni | Kelli M. Sas | Jennifer Hawkins | Keith Bellovich | Jaeman Byun | F. Afshinnia | Stefanie Wernisch | Jennifer J. Hawkins
[1] Hyun Soon Lee,et al. Palmitate induces mitochondrial superoxide generation and activates AMPK in podocytes , 2017, Journal of cellular physiology.
[2] Y. Takeishi,et al. Associations between acylcarnitine to free carnitine ratio and adverse prognosis in heart failure patients with reduced or preserved ejection fraction , 2017, ESC heart failure.
[3] N. Vaziri,et al. Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism. , 2017, Journal of proteome research.
[4] X. Ruan,et al. Autophagy Protects against Palmitic Acid-Induced Apoptosis in Podocytes in vitro , 2017, Scientific Reports.
[5] Kumar Sharma,et al. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. , 2016, JCI insight.
[6] Jiang He,et al. Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort , 2016, Kidney international reports.
[7] A. Fornoni,et al. Systemic and renal lipids in kidney disease development and progression. , 2016, American journal of physiology. Renal physiology.
[8] E. D. de Geus,et al. Twin-sibling study and meta-analysis on the heritability of maximal oxygen consumption. , 2016, Physiological genomics.
[9] Y. Ohashi,et al. Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] J. Mattana,et al. Cholesterol Metabolism in CKD. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[11] G. Medina-Gómez,et al. Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes , 2015, PloS one.
[12] S. Choi,et al. Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress , 2015, Cell Death and Disease.
[13] Steven L Britton,et al. Maximal oxidative capacity during exercise is associated with skeletal muscle fuel selection and dynamic changes in mitochondrial protein acetylation. , 2015, Cell metabolism.
[14] D. Webb,et al. Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease[S] , 2015, Journal of Lipid Research.
[15] Kumar Sharma,et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development , 2014, Nature Medicine.
[16] A. Jehle,et al. Free Fatty Acids and Their Metabolism Affect Function and Survival of Podocytes , 2014, Front. Endocrinol..
[17] Dahai Liu,et al. Predicting cardiovascular mortality in chronic kidney disease (CKD) patients. , 2014, Annals of transplantation.
[18] T. Uzu,et al. Fatty acids are novel nutrient factors to regulate mTORC1 lysosomal localization and apoptosis in podocytes. , 2014, Biochimica et biophysica acta.
[19] A. Jehle,et al. Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2. , 2014, American journal of physiology. Renal physiology.
[20] F. Hou,et al. The effect of inhibition of endoplasmic reticulum stress on lipolysis in white adipose tissue in a rat model of chronic kidney disease , 2014, Acta Pharmacologica Sinica.
[21] A. Kontush,et al. Unraveling the complexities of the HDL lipidome1 , 2013, Journal of Lipid Research.
[22] C. Cohen,et al. Susceptibility of podocytes to palmitic acid is regulated by stearoyl-CoA desaturases 1 and 2. , 2013, The American journal of pathology.
[23] L. Tarasenko,et al. Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001–2010 , 2013, BMC Nephrology.
[24] O. Fiehn,et al. Induced Pluripotent Stem Cells Show Metabolomic Differences to Embryonic Stem Cells in Polyunsaturated Phosphatidylcholines and Primary Metabolism , 2012, PloS one.
[25] C. Hoppel,et al. Oxidation of Fatty Acids Is the Source of Increased Mitochondrial Reactive Oxygen Species Production in Kidney Cortical Tubules in Early Diabetes , 2012, Diabetes.
[26] T. Kassimatis,et al. Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era. , 2012, Journal of nephrology.
[27] Yu-Shen Cheng,et al. Qualitative analysis of algal secretions with multiple mass spectrometric platforms. , 2012, Journal of chromatography. A.
[28] Natalie I. Tasman,et al. A Cross-platform Toolkit for Mass Spectrometry and Proteomics , 2012, Nature Biotechnology.
[29] P. Neufer,et al. Lipid-induced mitochondrial stress and insulin action in muscle. , 2012, Cell metabolism.
[30] Edward A Dennis,et al. The human plasma lipidome. , 2011, The New England journal of medicine.
[31] M. Rydén,et al. Uraemic sera stimulate lipolysis in human adipocytes: role of perilipin. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[32] M. Landray,et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.
[33] Christophe Ladroue,et al. Comparative Lipidomics Profiling of Human Atherosclerotic Plaques , 2011, Circulation. Cardiovascular genetics.
[34] S. Carr,et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. , 2011, The Journal of clinical investigation.
[35] T. Uzu,et al. Oleate and eicosapentaenoic acid attenuate palmitate-induced inflammation and apoptosis in renal proximal tubular cell. , 2010, Biochemical and biophysical research communications.
[36] C. Cohen,et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. , 2010, American journal of physiology. Renal physiology.
[37] R. Gerszten,et al. Metabolite profiling identifies markers of uremia. , 2010, Journal of the American Society of Nephrology : JASN.
[38] R. Wanders,et al. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation , 2010, Journal of Inherited Metabolic Disease.
[39] J. Tavaré,et al. Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. , 2009, Nephrology, Dialysis and Transplantation.
[40] J. Hardin,et al. The joint effects of cardiorespiratory fitness and adiposity on mortality risk in men with hypertension. , 2009, American journal of hypertension.
[41] Stefan R. Bornstein,et al. Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients , 2009, PloS one.
[42] Keith C. Norris,et al. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. , 2009, American journal of physiology. Renal physiology.
[43] Gert Mayer,et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.
[44] Vagner Milani,et al. Prevalence of 4977bp Deletion in Mitochondrial DNA from Patients with Chronic Kidney Disease Receiving Conservative Treatment or Hemodialysis in Southern Brazil , 2008, Renal failure.
[45] C. Saha,et al. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[46] Marko Sysi-Aho,et al. Acquired Obesity Is Associated with Changes in the Serum Lipidomic Profile Independent of Genetic Effects – A Monozygotic Twin Study , 2007, PloS one.
[47] K. Petersen,et al. Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction , 2006, Diabetes.
[48] B. Walters,et al. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease. , 2006, Clinical nephrology.
[49] A. Volchuk,et al. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. , 2006, Endocrinology.
[50] S. Perkins,et al. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[51] R. Trevisan,et al. Lipids and renal disease. , 2006, Journal of the American Society of Nephrology : JASN.
[52] J. Kampert,et al. Cardiorespiratory Fitness Is Inversely Associated With the Incidence of Metabolic Syndrome: A Prospective Study of Men and Women , 2005, Circulation.
[53] W. März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.
[54] K. Petersen,et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.
[55] N. Vaziri,et al. Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis. , 2003, Kidney international.
[56] T. Pesavento,et al. Culture-negative peritoneal dialysis peritonitis associated with pancreaticoduodenocystotomy leak of a pancreas transplant. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[57] N. Vaziri. Molecular mechanisms of lipid disorders in nephrotic syndrome. , 2003, Kidney international.
[58] C. Hoppel. The role of carnitine in normal and altered fatty acid metabolism. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[59] N. Powe,et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. , 2002, Journal of the American Society of Nephrology : JASN.
[60] Yau-Huei Wei,et al. Mitochondrial DNA mutations and oxidative damage in skeletal muscle of patients with chronic uremia. , 2002, Journal of biomedical science.
[61] Y. Wei,et al. Biomarkers of DNA damage in patients with end-stage renal disease: mitochondrial DNA mutation in hair follicles. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[62] K. Liestøl,et al. Changes in physical fitness and changes in mortality , 1998, The Lancet.
[63] S. Massry,et al. Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. , 1996, The Journal of clinical investigation.
[64] N. Altman. An Introduction to Kernel and Nearest-Neighbor Nonparametric Regression , 1992 .
[65] P. Attman,et al. Lipid abnormalities in chronic renal insufficiency. , 1991, Kidney international. Supplement.
[66] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.